Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Correlation of limited-early-response status with 12-month CST, BVA, and machine learning-quantified retinal fluid in diabetic macular oedema in routine clinical practice

Eye(2024)10.1038/s41433-024-03172-4Source: DataRank Database

Correlation of limited-early-response status with 12-month CST, BVA, and machine learning-quantified retinal fluid in diabetic macular oedema in routine clinical practice is a research paper published in Eye (2024). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.57)OA: hybridTopics (65)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Scott W. Perkins,Aneesha Kalur,Rishi P. Singh ORCID,Resya Sastry

Live enrichment

PubMed:38890549 PMC:PMC11427467 OpenAlex:https://openalex.org/W4399759800

U.S. Department of Health & Human Services | NIH | National Eye Institute

Grant: IP30EY025585

NEI NIH HHS

Grant: P30 EY025585

National Institutes of Health

Grant: 5P30EY025585-04

NEI CENTER CORE GRANT FOR VISION RESEARCH

Research to Prevent Blindness

FWCI

1.57

Citation Percentile

0.8%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1038/s41433-024-03172-4

HYBRIDhttps://doi.org/10.1038/s41433-024-03172-4

publisherhttps://doi.org/10.1038/s41433-024-03172-4

publisherhttps://www.nature.com/articles/s41433-024-03172-4.pdf

publisherhttps://www.nature.com/articles/s41433-024-03172-4

Fields of Study

Retinal Diseases and TreatmentsRetinal Imaging and AnalysisRetinal and Macular SurgeryMedicine0301 basic medicine03 medical and health sciences0302 clinical medicineHumansTomography, Optical CoherenceMachine LearningMaleMacular EdemaDiabetic RetinopathyVisual AcuityFemaleMiddle AgedSubretinal FluidAngiogenesis InhibitorsAgedVascular Endothelial Growth Factor AIntravitreal InjectionsRanibizumabRetrospective StudiesBevacizumab

MeSH Terms

BevacizumabMachine LearningRanibizumabAgedDiabetic RetinopathyFemaleHumansMacular EdemaMaleMiddle AgedRetrospective StudiesVisual AcuityAngiogenesis InhibitorsTomography, Optical CoherenceVascular Endothelial Growth Factor AIntravitreal InjectionsSubretinal Fluid

Keywords

MedicineRetinalOphthalmologyVisual acuityDiabetic retinopathyOptical coherence tomographySurgeryDiabetes mellitusMaleVascular Endothelial Growth Factor ASubretinal FluidAngiogenesis InhibitorsMiddle AgedArticleMacular EdemaMachine LearningBevacizumabRanibizumabIntravitreal InjectionsHumansFemaleTomography, Optical CoherenceAgedRetrospective Studies

Sustainable Development Goals

SDG 0: Quality Education